Φορτώνει......
Bruton tyrosine kinase inhibitors for the frontline treatment of chronic lymphocytic leukemia
Chronic lymphocytic leukemia (cll) is the most commonly diagnosed adult leukemia in Canada. Biologic heterogeneity of cll between patients results in variable disease trajectories and responses to therapy. Notably, compared with patients lacking high-risk features, those with such features—such as d...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Curr Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Multimed Inc.
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7755444/ https://ncbi.nlm.nih.gov/pubmed/33380880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3747/co.27.6795 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|